Hans Peter Hasler has been named chief operating officer, Biogen Idec. Mr. Hasler has served as executive vice president, global neurology and head of International. In his new role, he will oversee all commercial operations as well as the company’s business development function.
   
“In view of the continued expansion of our commercial businesses, and the advances of our extensive pipeline, it is important to further integrate Biogen Idec’s commercial units,” said James C. Mullen, Biogen Idec’s chief executive officer. “Bringing together these businesses to enhance our commercial and new product opportunities on a global basis is a logical step in the continued implementation of our growth strategy -- and Hans Peter Hasler is the ideal person to fill this new organizational role. Over the last few years, Hans Peter has led the great success and growth of our business outside the U.S. I am confident that we will continue meeting and exceeding our goals under his strong and capable leadership.”
   
Mr. Hasler joined the company in 2001 from Wyeth Pharmaceuticals where he worked for eight years, serving since 1998 as senior vice president, head of Global Strategic Marketing. He was also a member of the Wyeth executive committee and chair of the Commercial Council. From 1993 to 1998, he served in senior management capacities, including managing director of Wyeth Group, Germany; general manager of Wyeth in Switzerland; and general manager of central Eastern Europe. Prior to joining Wyeth, Mr. Hasler held several positions at Abbott and Sanofi Pharma in Switzerland.

Bilcare Global Clinical Supplies has completed the expansion of its warehouse facility in Phoenixville, PA, doubling ambient storage capacity at the facility. This expansion is part of a four-phase project to expand the warehouse and distribution area. The project is scheduled for completion in the third quarter of this year.     
   
“The increase in storage capacity is the next step in a series of global upgrades designed to demonstrate to customers that Bilcare is a company focused on providing high-quality service and cutting-edge technology for its customers to ensure on-time project completion,” said Bilcare GCS Americas president, Vincent Santa Maria.
    
During the last several months, the company has made improvements globally including increasing the number of its packaging rooms, upgrading equipment, expanding its storage and distribution facilities, enhancing its formulation and analytical development services and technical capabilities, improving its IVRS/IWRS capabilities and integrating global operations.   

Catalent Pharma Solutions is now offering warehousing and worldwide logistics solutions for storage, distribution, management, and the fulfillment of compliance requirements. The company's logistics services provide for short- or long-term storage in cGMP facilities for drug products, pharmaceutical excipients, and APIs, including potent APIs.
    
Warehousing services include: cGMP drug product and cGMP bulk API warehousing with storage of small and large quantities at controlled temperatures of 15°C to 25°C, refrigerator (2°C to 8°C), and freezer (-25°C to -15°C). Services include shipments to customer-designated sites, inventory counts, and destruction. Additional services for cGMP bulk API include dispensing, shipment preparation, retaining samples, fulfillment and shipment services, and handling of both non-potent and potent APIs.
   
Worldwide logistics services include: compliance management, managed import process, import/export permitting (CBP, FDA, DEA), logistics and transportation management, free trade zone service, export process management, import/export compliance audit program, and freight pay and audit services.